65 related articles for article (PubMed ID: 1586989)
1. Tissue distribution of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in two strains of male rats.
Tjøtta K; Ingebrigtsen K; Aune T
Carcinogenesis; 1992 May; 13(5):779-82. PubMed ID: 1586989
[TBL] [Abstract][Full Text] [Related]
2. Disposition and metabolism of the food mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in rats.
Sjödin P; Wallin H; Alexander J; Jägerstad M
Carcinogenesis; 1989 Jul; 10(7):1269-75. PubMed ID: 2661045
[TBL] [Abstract][Full Text] [Related]
3. Distribution and elimination of [2-14C]amino-3,8-dimethylimidazo [4, 5-f] quinoxaline in mice. Analysis by whole animal autoradiography.
Gooderham NJ; Soames A; Rice JC; Boobis AR; Davies DS
Hum Exp Toxicol; 1991 Sep; 10(5):337-45. PubMed ID: 1683547
[TBL] [Abstract][Full Text] [Related]
4. Dose-response studies of MeIQx in rat liver and liver DNA at low doses.
Frantz CE; Bangerter C; Fultz E; Mayer KM; Vogel JS; Turteltaub KW
Carcinogenesis; 1995 Feb; 16(2):367-73. PubMed ID: 7859370
[TBL] [Abstract][Full Text] [Related]
5. The effect of dose and cytochrome P450 induction on the metabolism and disposition of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx) in the rat.
Turesky RJ; Markovic J; Bracco-Hammer I; Fay LB
Carcinogenesis; 1991 Oct; 12(10):1847-55. PubMed ID: 1934266
[TBL] [Abstract][Full Text] [Related]
6. Disposition of the Dietary Mutagen 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline in Healthy and Pancreatic Cancer Compromised Humans.
Malfatti MA; Kuhn EA; Turteltaub KW; Vickers SM; Jensen EH; Strayer L; Anderson KE
Chem Res Toxicol; 2016 Mar; 29(3):352-8. PubMed ID: 26918625
[TBL] [Abstract][Full Text] [Related]
7. Effects of enzyme induction on the distribution of the food carcinogen 2-amino-3,8-dimethyl-imidazo[4,5-ss]-quinoxaline (MeIQx) in Ah-receptor- responsive- and Ah-receptor-non-responsive mice.
Vikse R; Ingebrigtsen K; Klungsøyr L; Alexander J
Pharmacol Toxicol; 1995 Jul; 77(1):57-64. PubMed ID: 8532613
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of the food-borne mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans.
Turesky RJ; Garner RC; Welti DH; Richoz J; Leveson SH; Dingley KH; Turteltaub KW; Fay LB
Chem Res Toxicol; 1998 Mar; 11(3):217-25. PubMed ID: 9544620
[TBL] [Abstract][Full Text] [Related]
9. Covalent binding of [2-14C]2-amino-3,8-dimethylimidazo[4,5-f]-quinoxaline (MeIQx) to mouse DNA in vivo.
Alldrick AJ; Lutz WK
Carcinogenesis; 1989 Aug; 10(8):1419-23. PubMed ID: 2665966
[TBL] [Abstract][Full Text] [Related]
10. DNA adducts formed by 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat liver: dose-response on chronic administration.
Yamashita K; Adachi M; Kato S; Nakagama H; Ochiai M; Wakabayashi K; Sato S; Nagao M; Sugimura T
Jpn J Cancer Res; 1990 May; 81(5):470-6. PubMed ID: 2116395
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of the food-borne mutagen/carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in the rat: assessment of biliary metabolites for genotoxicity.
Turesky RJ; Aeschbacher HU; Malnoë A; Würzner HP
Food Chem Toxicol; 1988 Feb; 26(2):105-10. PubMed ID: 3366409
[TBL] [Abstract][Full Text] [Related]
12. Distribution of radiolabelled [2-14C]IQ and MeIQx in the mouse.
Alldrick AJ; Rowland IR
Toxicol Lett; 1988 Nov; 44(1-2):183-90. PubMed ID: 3188077
[TBL] [Abstract][Full Text] [Related]
13. Intra- and interindividual variability in systemic exposure in humans to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline and 2-amino-1-methyl- 6-phenylimidazo[4,5-b]pyridine, carcinogens present in cooked beef.
Lynch AM; Knize MG; Boobis AR; Gooderham NJ; Davies DS; Murray S
Cancer Res; 1992 Nov; 52(22):6216-23. PubMed ID: 1423264
[TBL] [Abstract][Full Text] [Related]
14. MeIQx (2-amino-3,8-dimethylimidazo [4,5-f]quinoxaline): metabolism in humans and urinary metabolites in human populations.
Tannenbaum SR; Stillwell WG; Ji H; Skipper PL; Yu MC; Ross RK; Henderson BE; Turesky RJ; Gross GA
Princess Takamatsu Symp; 1995; 23():197-206. PubMed ID: 8844811
[TBL] [Abstract][Full Text] [Related]
15. Major routes of metabolism of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in the rat.
Turesky RJ; Aeschbacher HU; Würzner HP; Skipper PL; Tannenbaum SR
Carcinogenesis; 1988 Jun; 9(6):1043-8. PubMed ID: 3370749
[TBL] [Abstract][Full Text] [Related]
16. Metabolic processing and disposition of 2-amino-3-methylimidazo[4,5-f] quinoline (IQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates.
Snyderwine EG; Turesky RJ; Buonarati MH; Turteltaub KW; Adamson RH
Princess Takamatsu Symp; 1995; 23():69-77. PubMed ID: 8844797
[TBL] [Abstract][Full Text] [Related]
17. Effect of dietary fiber on the disposition and excretion of a food carcinogen (2-14C-labeled MeIQx) in rats.
Sjödin P; Nyman M; Nielsen LL; Wallin H; Jägerstad M
Nutr Cancer; 1992; 17(2):139-51. PubMed ID: 1316601
[TBL] [Abstract][Full Text] [Related]
18. Gut microbial transformation of the dietary mutagen MeIQx may reduce exposure levels without altering intestinal transport.
Zhang J; Empl MT; Schneider M; Schröder B; Stadnicka-Michalak J; Breves G; Steinberg P; Sturla SJ
Toxicol In Vitro; 2019 Sep; 59():238-245. PubMed ID: 30954653
[TBL] [Abstract][Full Text] [Related]
19. Possible relationship between tissue distribution of DNA adducts and genotoxicity of food-derived heterocyclic amines.
Thorgeirsson SS; Davis CD; Schut HA; Adamson RH; Snyderwine EG
Princess Takamatsu Symp; 1995; 23():85-92. PubMed ID: 8844799
[TBL] [Abstract][Full Text] [Related]
20. Comparison of DNA-adduct and tissue-available dose levels of MeIQx in human and rodent colon following administration of a very low dose.
Mauthe RJ; Dingley KH; Leveson SH; Freeman SP; Turesky RJ; Garner RC; Turteltaub KW
Int J Cancer; 1999 Feb; 80(4):539-45. PubMed ID: 9935154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
